Gano Kyle bought NBIX
September 11, 2026 · Form 4 insider transaction
Gano Kyle bought 1,842 shares of Neurocrine Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,842
Price
$0.00
Total value
N/A
InsiderGano Kyle
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateSeptember 11, 2026
Filing dateSeptember 15, 2026
Shares owned after155,722
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Reporting Person was previously granted performance restricted stock units (PRSUs) that vest upon the achievement of certain performance metrics, the achievement of one of which was certified on September 11, 2026.